Page last updated: 2024-09-03
ly 255283 and cn 100
ly 255283 has been researched along with cn 100 in 1 studies
Compound Research Comparison
| Studies (ly 255283) | Trials (ly 255283) | Recent Studies (post-2010) (ly 255283) | Studies (cn 100) | Trials (cn 100) | Recent Studies (post-2010) (cn 100) |
|---|---|---|---|---|---|
| 54 | 0 | 15 | 27 | 2 | 10 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bischoff-Kont, I; Fürst, R; Heering, J; Hernandez-Olmos, V; Kaps, A; Liu, T; Proschak, E; Rajkumar, R; Steinhilber, D | 1 |
Other Studies
1 other study(ies) available for ly 255283 and cn 100
| Article | Year |
|---|---|
Discovery of Irbesartan Derivatives as BLT2 Agonists by Virtual Screening.
Topics: | 2021 |